BioXcel Therapeutics files Chapter 11 bankruptcy
BioXcel Therapeutics filed for Chapter 11 bankruptcy and estimated liabilities up to $500 million versus assets as low as $10 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.